Atlantic Private Wealth LLC acquired a new position in shares of Colgate-Palmolive (NYSE:CL – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor acquired 1,753 shares of the company’s stock, valued at approximately $159,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Chicago Partners Investment Group LLC grew its position in shares of Colgate-Palmolive by 16.2% during the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock worth $591,000 after buying an additional 943 shares in the last quarter. Peak Financial Advisors LLC acquired a new position in shares of Colgate-Palmolive during the fourth quarter worth about $1,315,000. Fiduciary Alliance LLC purchased a new stake in Colgate-Palmolive during the fourth quarter worth approximately $4,066,000. Impact Partnership Wealth LLC purchased a new stake in Colgate-Palmolive during the fourth quarter worth approximately $803,000. Finally, Barclays PLC lifted its stake in Colgate-Palmolive by 38.7% during the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after purchasing an additional 2,132,747 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
CL has been the subject of several recent analyst reports. UBS Group decreased their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Raymond James restated an “outperform” rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. JPMorgan Chase & Co. boosted their target price on Colgate-Palmolive from $97.00 to $99.00 and gave the stock an “overweight” rating in a research note on Friday, March 14th. Piper Sandler decreased their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Finally, StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Friday, March 14th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Hold” and an average target price of $101.72.
Colgate-Palmolive Trading Up 1.1 %
Shares of CL stock opened at $90.44 on Thursday. The business’s fifty day moving average price is $89.19 and its 200 day moving average price is $94.41. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The firm has a market capitalization of $73.39 billion, a PE ratio of 25.69, a P/E/G ratio of 4.20 and a beta of 0.40. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the firm earned $0.87 EPS. As a group, sell-side analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- 3 Small Caps With Big Return Potential
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- What is a Low P/E Ratio and What Does it Tell Investors?
- Alphabet’s Officially In A Bear Market—Time To Buy?
- What is the Hang Seng index?
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.